- Home
- FRES vs OGEN Comparison
FRES vs OGEN Comparison
Compare FRES & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRES
- OGEN
- Stock Information
- Founded
- FRES 2010
- OGEN 1996
- Country
- FRES United States
- OGEN United States
- Employees
- FRES N/A
- OGEN N/A
- Industry
- FRES Medical Specialities
- OGEN Biotechnology: Pharmaceutical Preparations
- Sector
- FRES Health Care
- OGEN Health Care
- Exchange
- FRES Nasdaq
- OGEN Nasdaq
- Market Cap
- FRES N/A
- OGEN 4.5M
- IPO Year
- FRES 2020
- OGEN N/A
- Fundamental
- Price
- FRES $1.66
- OGEN $0.34
- Analyst Decision
- FRES
- OGEN
- Analyst Count
- FRES 0
- OGEN 0
- Target Price
- FRES N/A
- OGEN N/A
- AVG Volume (30 Days)
- FRES 32.8K
- OGEN 392.1K
- Earning Date
- FRES 10-29-2024
- OGEN 11-07-2024
- Dividend Yield
- FRES N/A
- OGEN N/A
- EPS Growth
- FRES N/A
- OGEN N/A
- EPS
- FRES N/A
- OGEN N/A
- Revenue
- FRES $2,341,326.00
- OGEN $7,466.00
- Revenue This Year
- FRES N/A
- OGEN N/A
- Revenue Next Year
- FRES N/A
- OGEN N/A
- P/E Ratio
- FRES N/A
- OGEN N/A
- Revenue Growth
- FRES 94.50
- OGEN N/A
- 52 Week Low
- FRES $1.11
- OGEN $0.29
- 52 Week High
- FRES $18.00
- OGEN $7.74
- Technical
- Relative Strength Index (RSI)
- FRES 51.75
- OGEN 36.96
- Support Level
- FRES $1.51
- OGEN $0.29
- Resistance Level
- FRES $2.36
- OGEN $0.35
- Average True Range (ATR)
- FRES 0.19
- OGEN 0.04
- MACD
- FRES 0.06
- OGEN 0.02
- Stochastic Oscillator
- FRES 38.60
- OGEN 31.19
About OGEN Oragenics Inc.
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification.